Cargando…

Refractory Kawasaki disease: diagnostic and management challenges

Kawasaki disease (KD), an acute, self-limiting, medium-sized arterial vasculitis, is now the most common cause of acquired heart disease in childhood in the developed world. In this review, we discuss the diagnosis of KD, predicting resistance to traditional therapy and treatment options in refracto...

Descripción completa

Detalles Bibliográficos
Autores principales: Duignan, Sophie, Doyle, Sarah L, McMahon, Colin J
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6826175/
https://www.ncbi.nlm.nih.gov/pubmed/31802968
http://dx.doi.org/10.2147/PHMT.S165935
_version_ 1783465031283769344
author Duignan, Sophie
Doyle, Sarah L
McMahon, Colin J
author_facet Duignan, Sophie
Doyle, Sarah L
McMahon, Colin J
author_sort Duignan, Sophie
collection PubMed
description Kawasaki disease (KD), an acute, self-limiting, medium-sized arterial vasculitis, is now the most common cause of acquired heart disease in childhood in the developed world. In this review, we discuss the diagnosis of KD, predicting resistance to traditional therapy and treatment options in refractory or high-risk disease. We also highlight ongoing clinical trials and other potential avenues of research which may prove beneficial in managing children, especially those with resistant KD.
format Online
Article
Text
id pubmed-6826175
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher Dove
record_format MEDLINE/PubMed
spelling pubmed-68261752019-12-04 Refractory Kawasaki disease: diagnostic and management challenges Duignan, Sophie Doyle, Sarah L McMahon, Colin J Pediatric Health Med Ther Review Kawasaki disease (KD), an acute, self-limiting, medium-sized arterial vasculitis, is now the most common cause of acquired heart disease in childhood in the developed world. In this review, we discuss the diagnosis of KD, predicting resistance to traditional therapy and treatment options in refractory or high-risk disease. We also highlight ongoing clinical trials and other potential avenues of research which may prove beneficial in managing children, especially those with resistant KD. Dove 2019-10-30 /pmc/articles/PMC6826175/ /pubmed/31802968 http://dx.doi.org/10.2147/PHMT.S165935 Text en © 2019 Duignan et al. http://creativecommons.org/licenses/by-nc/3.0/ This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/). By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).
spellingShingle Review
Duignan, Sophie
Doyle, Sarah L
McMahon, Colin J
Refractory Kawasaki disease: diagnostic and management challenges
title Refractory Kawasaki disease: diagnostic and management challenges
title_full Refractory Kawasaki disease: diagnostic and management challenges
title_fullStr Refractory Kawasaki disease: diagnostic and management challenges
title_full_unstemmed Refractory Kawasaki disease: diagnostic and management challenges
title_short Refractory Kawasaki disease: diagnostic and management challenges
title_sort refractory kawasaki disease: diagnostic and management challenges
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6826175/
https://www.ncbi.nlm.nih.gov/pubmed/31802968
http://dx.doi.org/10.2147/PHMT.S165935
work_keys_str_mv AT duignansophie refractorykawasakidiseasediagnosticandmanagementchallenges
AT doylesarahl refractorykawasakidiseasediagnosticandmanagementchallenges
AT mcmahoncolinj refractorykawasakidiseasediagnosticandmanagementchallenges